EUVIMEDEUVIMED entdecken
Leserbrief

Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome

Amir Lotfi

JACC: Cardiovascular Interventions · 2026-05 · 19 (9) · 1192

DOI: 10.1016/j.jcin.2026.02.044 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JACC: Cardiovascular Interventions, 2026-05. Verfasst von Amir Lotfi. Beteiligte Einrichtung: Division of Cardiology, Baystate Medical Center, Springfield, Massachusetts. Electronic address: amir.lotfi@baystatehealth.org. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Cardiology, Baystate Medical Center, Springfield, Massachusetts. Electronic address: amir.lotfi@baystatehealth.org.

Zitieren

APA

Lotfi, A. (2026). Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome. JACC: Cardiovascular Interventions, 19(9), 1192. https://doi.org/10.1016/j.jcin.2026.02.044

Vancouver

Lotfi A. Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome. JACC: Cardiovascular Interventions. 2026;19(9):1192. doi:10.1016/j.jcin.2026.02.044

BibTeX
@article{Lotfi2026,
  author = {Lotfi, Amir},
  title = {Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {9},
  pages = {1192},
  doi = {10.1016/j.jcin.2026.02.044}
}
Kostenlos starten →